Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02540928
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
3BK | (2R,3R,4S,5R)-2-[6-amino-8-[(3,4- dichlorophenyl)methylamino]purin- 9-yl]-5-(hydroxymethyl)oxolane- 3,4-diol | A | 3FZK | 0.74 |  |
A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A,B,C,D | 1PZG | 0.73 | |
| A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A | 1DRV | 0.73 | |
| A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A,B | 2EWD | 0.73 | |
| A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A,B,C,D | 1PZF | 0.73 | |
5HI | (3R,5R)-7-[2-(4-fluorophenyl)-4- {[(1S)-2-hydroxy-1-phenylethyl]carbamoyl}- 5-(1-methylethyl)-1H-imidazol-1- yl]-3,5-dihydroxyheptanoic acid | A,B,C,D | 3CCZ | 0.73 | |
1DG | (4R)-ISONICOTINIC-ACETYL-NICOTINAMIDE- ADENINE DINUCLEOTIDE | A | 2CIG | 0.75 | |
447 | N-(4-{[6-methoxy-7-(3-morpholin- 4-ylpropoxy)quinazolin-4-yl]amino}phenyl)benzamide | A,B | 2VRX | 0.7 | |
3GO | 4-[[(2R,3S,4R,5R)-5-[6-amino-8- (quinolin-6-ylmethylamino)purin- 9-yl]-3,4-dihydroxy-oxolan-2-yl]methoxymethyl]benzonitrile | A | 3FZM | 0.76 | |
4CA | 4-HYDROXYBENZYL COENZYME A | A | 1LO8 | 0.72 | |
| 4CA | 4-HYDROXYBENZYL COENZYME A | A | 1Q4U | 0.72 | |
6FA | 6-HYDROXY-FLAVIN-ADENINE DINUCLEOTIDE | A,B | 1NAA | 0.7 | |
| 6FA | 6-HYDROXY-FLAVIN-ADENINE DINUCLEOTIDE | A,B | 1KDG | 0.7 | |
4CO | 4-HYDROXYPHENACYL COENZYME A | A,B | 1Q4T | 0.74 | |
| 4CO | 4-HYDROXYPHENACYL COENZYME A | A | 1LO7 | 0.74 | |
4HI | (3R,5R)-7-[4-(benzylcarbamoyl)- 2-(4-fluorophenyl)-5-(1-methylethyl)- 1H-imidazol-1-yl]-3,5-dihydroxyheptanoic acid | B,C,D | 3CCW | 0.72 | |
1PM | methyl (3S)-3-{2-[(1,3-benzodioxol- 5-ylmethyl)amino]-2-oxoethyl}-4- [2-(1H-imidazol-1-yl)pyrimidin- 4-yl]piperazine-1-carboxylate | A | 1DD7 | 0.71 | |
3FD | 4-[[(2R,3S,4R,5R)-5-[6-amino-8- [(3,4-dichlorophenyl)methylamino]purin- 9-yl]-3,4-dihydroxy-oxolan-2-yl]methoxymethyl]benzonitrile | A | 3FZL | 0.78 | |
00A | 5'-O-[(S)-{[(4-chlorophenyl)carbonyl]oxy}(hydroxy)phosphoryl]adenosine | X | 3CW8 | 0.83 | |
7CS | (3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT- 3-YL 1H-PYRROLO[2,3-B]PYRIDINE- 3-CARBOXYLATE | A | 2QHM | 0.71 | |
8ID | NICOTINAMIDE-8-IODO-ADENINE-DINUCLEOTIDE | A,B,C,D | 2HCY | 0.73 | |
4RB | 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2- b]pyridazin-3-yl)benzoic acid | A | 3BQR | 0.72 | |
090 | N-(2,3-DIHYDRO-7,8-DIMETHOXYIMIDAZO[1,2- C] QUINAZOLIN-5-YL)NICOTINAMIDE | A | 2CHX | 0.7 | |
ABR | (R)-(N-PHENYL-2-HYDROXY-ETHYL)- 2'-DEOXY-ADENOSINE-5'-MONOPHOSPHATE | A | 1K5E | 0.79 | |
6HI | (3R,5R)-7-{2-[(4-fluorobenzyl)carbamoyl]- 4-(4-fluorophenyl)-1-(1-methylethyl)- 1H-imidazol-5-yl}-3,5-dihydroxyheptanoic acid | B,C,D | 3CD0 | 0.7 | |
01A | 4-Chlorophenacyl-coenzyme A | A,B | 3CW9 | 0.72 | |